Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...
Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.
Believe it or not, there's something worse than male pattern baldness. It's depression, plunging libido and shrinking ...
Telehealth companies like Hims & Hers (HIMS) are aggressively marketing hair-loss medications to young men, with some patients saying they ...
Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...
Step right up, ladies and gentlemen, and welcome to the hottest new spot in town: The Weight-Loss Casino! Here, you don’t ...
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
15d
Investor's Business Daily on MSNBehind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats UpHims & Hers Health put out a jaw dropping commercial. Now, Hims stock is just dropping, as its semaglutide business faces a ...
Former US Army Sgt. Mark Millich’s sex drive plummeted — and his genitals shrank and changed shape after taking popular hair-loss drug finasteride.
A man has claimed his genitals 'shrank and changed shape' after taking a hair loss drug. According to the Wall Street Journal ...
Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...
From STAT’s Elaine Chen: A federal judge this week ruled against a compounding trade group that wanted to continue making ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results